MedTrace Logo

Clinical Use of Parental Support To Detect Single Gene Mutations

NCT01197872 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2013-07-16

No results posted yet for this study

Summary

Gene Security Network has developed a novel technology called Parental Support (PS) which is used for Preimplantation Genetic Screening/Diagnosis (PGS/D) during in vitro fertilization (IVF). This technology allows IVF physicians to identify embryos, prior to transfer to the uterus, which have the best chance of developing into healthy children.

Conditions

  • Single Gene Disorders

Interventions

OTHER

Preimplantation Genetic Diagnosis

Genetic testing on embryos to identify embryos that are affected by a single gene disorder (e.g. cystic fibrosis, Tay-Sachs, sickle cell anemia).

Sponsors & Collaborators

  • Natera, Inc.

    lead INDUSTRY

Principal Investigators

  • Matthew Rabinowitz, PhD · CEO, Gene Security Network

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197872 on ClinicalTrials.gov